Product Information
MEDROL 4 MG DOSEPAK is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $0.2911 per EA under NDC 00009005604. Its NADAC has been published 503 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009005604
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPREDNISOLONEApproval Type
New Drug (NDA)
FDA Application
NDA011153FDA Approved
Before 1982
TE Code
AB
On Market Since
10/24/1957
Pharmacological Classes
Price Statistics
The NADAC for MEDROL 4 MG DOSEPAK has been published 503 times since Nov 28, 2013, and over the history we have for it it has declined 79.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2911 per EA |
|---|---|
| All-time high | $2.9894 (Jan 16, 2019) |
| All-time low | $0.2552 (Jul 17, 2024) |
| 52-week high | $0.2916 |
| 52-week low | $0.2908 |
| Median price | $1.5256 |
| Average price | $1.3298 |
| Largest weekly change | -90.3% (Mar 17, 2021) |
| Weeks tracked | 503 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 58% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pharmacia & Upjohn Company LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
methylprednisolone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEDROL 4 MG DOSEPAK?
The current National Average Drug Acquisition Cost (NADAC) for MEDROL 4 MG DOSEPAK, manufactured by Pharmacia & Upjohn Company LLC, is $0.2911 per EA (NDC 00009005604), effective Sep 30, 2026.
How has the price of MEDROL 4 MG DOSEPAK changed over time?
Over the history we have for it, the NADAC for MEDROL 4 MG DOSEPAK has declined 79.6%. It has been tracked across 503 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MEDROL 4 MG DOSEPAK?
Since Nov 28, 2013, the NADAC for MEDROL 4 MG DOSEPAK has ranged from a low of $0.2552 (Jul 17, 2024) to a high of $2.9894 (Jan 16, 2019), with a median of $1.5256 per EA.
Are there cheaper alternatives to MEDROL 4 MG DOSEPAK?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPREDNISOLONE 4 MG TABLET, is $0.1211 per EA — about 58% below MEDROL 4 MG DOSEPAK.
Who manufactures MEDROL 4 MG DOSEPAK?
MEDROL 4 MG DOSEPAK (NDC 00009005604) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.